SR ONE CAPITAL MANAGEMENT, LLC bought ODTX

May 11, 2026 · Form 4 insider transaction

SR ONE CAPITAL MANAGEMENT, LLC bought 61,762 shares of Odyssey Therapeutics, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
61,762
Price
N/A
Total value
N/A
Role10% owner
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateMay 11, 2026
Filing dateMay 11, 2026
Shares owned after734,868
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration.; The securities are directly held by SR One Capital Fund I Aggregator, LP ("SR One Fund I Aggregator"). SR One Capital Partners I, LP ("SR One Partners I") is the sole general partner of SR One Fund I Aggregator, and SR One Capital Management, LLC ("SR One Capital Management") is the sole general partner of SR One Partners I. Simeon George, M.D. is the managing member of SR One Capital Management. Each of SR One Capital Partners I, SR One Capital Management and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.

View the original Form 4 on SEC EDGAR
SR ONE CAPITAL MANAGEMENT, LLC bought ODTX: May 11, 2026 | Insider Trading Screener